RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $605 from $630 and keeps an Outperform rating on the shares. The company delivered a Q1 beat and raised 2025 procedure volume guidance but lowered gross margins on tariffs, the analyst tells investors in a research note. Intuitive Surgical has strong momentum with Q1 procedure volume/capital placements up 17% y/y, 2025 procedure outlook of 15-17% y/y, and a notable upcoming catalyst with the mid-2025 full dV5 launch, the firm adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target lowered to $542 from $560 at BTIG
- Morgan Stanley sees ‘strong entry point’ into Intuitive Surgical after Q1 report
- Intuitive Surgical price target lowered to $590 from $605 at Truist
- Intuitive Surgical price target lowered to $575 from $670 at Piper Sandler
- Intuitive Surgical price target lowered to $575 from $600 at Baird